Skip to main content
Log in

Inappropriate use of thyroid ultrasound: a systematic review and meta-analysis

  • Meta- Analysis
  • Published:
Endocrine Aims and scope Submit manuscript

Abstract

Purpose

Nearly half the cases of thyroid cancer, a malignancy rapidly rising in incidence within the United States, are attributable to small and asymptomatic papillary thyroid cancers that will not increase mortality. A primary driver of thyroid cancer overdiagnosis is ultrasound use. It is therefore valuable to understand how inappropriate use of thyroid ultrasound is defined, analyze the current evidence for its frequency, and identify interventions to lessen misuse.

Methods

Ovid MEDLINE(R), Ovid EMBASE, and Scopus databases were searched from inception to June 2020 for studies assessing inappropriate use of thyroid ultrasound. Reviewers, working independently and in duplicate, evaluated studies for inclusion, extracted data, and graded risk of bias. We used a random-effects model with a generalized linear mixed approach to calculate the mean overall proportion estimates of inappropriate use.

Results

Seven studies (total n = 1573) met the inclusion criteria with moderate to high risk of bias. Inappropriate thyroid ultrasound use was described variably, using published practice guidelines, third-party expert reviewers, or author interpretations of the literature. The overall frequency of inappropriate thyroid ultrasound use was 46% (95% CI 15–82%; n = 388) and 34% (95% CI 16–57%; n = 190) among studies using guideline based definitions. The pooled frequency of iUS due to thyroid dysfunction (either hypothyroidism or thyrotoxicosis) was 17% (95% CI 7–37%; n = 191) and the frequency of iUS due to nonspecific symptoms without a palpable mass was 11% (95% CI 5–22%; n = 124). No study examined interventions to address inappropriate use.

Conclusions

Low quality evidence suggests that inappropriate use of thyroid ultrasound is common. Interventional studies aiming to decrease the inappropriate use of thyroid ultrasound are urgently needed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Code availability

Available on Figshare: https://figshare.com/s/94b8b01d083e87b0b30f.

References

  1. L. Davies, H.G. Welch, Current thyroid cancer trends in the United States. JAMA Otolaryngol. Head Neck Surg. (2014) https://doi.org/10.1001/jamaoto.2014.1

  2. E. Lincango-Naranjo, P. Solis-Pazmino, O. El Kawkgi, J. Salazar-Vega, et al. Triggers of thyroid cancer diagnosis: a systematic review and meta-analysis. Endocrine (2021). https://doi.org/10.1007/s12020-020-02588-8

  3. L. Furuya-Kanamori, K.J.L. Bell, J. Clark, P. Glasziou, et al. Prevalence of differentiated thyroid cancer in autopsy studies over six decades: a meta-analysis. J Clin. Oncol. (2016). https://doi.org/10.1200/JCO.2016.67.7419

  4. M. Li, J.P. Brito, S. Vaccarella, Long-term declines of thyroid cancer mortality: an international age-period-cohort analysis. Thyroid (2020). https://doi.org/10.1089/thy.2019.0684

  5. P. Solis-Pazmino, J. Salazar-Vega, E. Lincango-Naranjo, C. Garcia, et al. Thyroid cancer overdiagnosis and overtreatment: a cross- sectional study at a thyroid cancer referral center in Ecuador. BMC Cancer (2021). https://doi.org/10.1186/s12885-020-07735-y

  6. J.P. Brito, I.D. Hay. Thyroid cancer: overdiagnosis of papillary carcinoma — who benefits? Nat. Rev. Endocrinol. (2017). https://doi.org/10.1038/nrendo.2016.224

  7. J.P. Brito, J.C. Morris, V.M. Montori, Thyroid cancer: Zealous imaging has increased detection and treatment of low risk tumours. BMJ (2013). https://doi.org/10.1136/bmj.f4706

  8. J.P. Brito, A.A. Nofal, V.M. Montori, I.D. Hay, et al. The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012. Thyroid (2015). https://doi.org/10.1089/thy.2014.0594

  9. N.H. Esfandiari, D.T. Hughes, D. Reyes-Gastelum, K.C. Ward, et al. Factors associated with diagnosis and treatment of thyroid microcarcinomas. J Clin. Endocrinol. Metab. (2019). https://doi.org/10.1210/jc.2019-01219

  10. R. Li, Y. Wang, L. Du. A rapidly increasing trend of thyroid cancer incidence in selected East Asian countries: joinpoint regression and age-period-cohort analyses. Gland Surg. (2020). https://doi.org/10.21037/gs-20-97

  11. M.R. Haymart, M. Banerjee, D. Reyes-Gastelum, E. Caoili, et al. Thyroid ultrasound and the increase in diagnosis of low-risk thyroid cancer. J Clin. Endocrinol. Metab. (2019). https://doi.org/10.1210/jc.2018-01933

  12. D. Moher, A. Liberati, J. Tetzlaff, D.G. Altman, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ (2009). https://doi.org/10.1136/bmj.b2535

  13. DistillerSR | Systematic Review and Literature Review Software by Evidence Partners. https://www.evidencepartners.com/products/distillersr-systematic-review-software/ (2019). Accessed 10 Nov 2019

  14. C. Luchini, B. Stubbs, M. Solmi, N. Veronese. Assessing the quality of studies in meta-analyses: advantages and limitations of the Newcastle Ottawa Scale. World J Meta-Analysis (2017). https://doi.org/10.13105/wjma.v5.i4.80

  15. G. Wells, B. Shea, D. O’Connell, J. Peterson, et al. Ottawa Hospital Research Institute. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. (2019). http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 9 August 2019

  16. T.A. Trikalinos, P. Trow, C.H. Schmid, Simulation-based comparison of methods for meta-analysis of proportions and rates. Methods Res. Rep. 13, 1–98 (2013)

    Google Scholar 

  17. C.J. Clopper, E.S. Pearson. The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika (1934). https://doi.org/10.1093/biomet/26.4.404

  18. J.P.T. Higgins, S.G. Thompson. Quantifying heterogeneity in a meta-analysis. Stat. Med. (2002). https://doi.org/10.1002/sim.1186

  19. RStudio: Integrated Development for R. RStudio PBM. RStudio team. (2020). https://rstudio.com/. Accessed 5 Aug 2020

  20. C. Davenport, J. Alderson, I.G. Yu, A.C. Magner, et al. A review of the propriety of thyroid ultrasound referrals and their follow-up burden. Endocrine (2019). https://doi.org/10.1007/s12020-019-01920-1

  21. F.G. Joseph, D. Rubtsov, P. Davoren. Appropriateness of ultrasound imaging for thyroid pathology, the standard of radiology reporting on thyroid nodules and the detection rates of thyroid malignancy: a tertiary centre retrospective audit. Intern. Med. J (2019). https://doi.org/10.1111/imj.14401

  22. B.A. Landry, D. Barnes, V. Keough, A. Watson et al. Do family physicians request ultrasound scans appropriately? Can. Fam. Phys. 57, 299–304 (2011)

    Google Scholar 

  23. Y. Liel, N. Fraenkel. Use and misuse of thyroid ultrasound in the initial workup of patients with suspected thyroid problems referred by primary care physicians to an endocrine clinic. J Gen. Intern. Med. (2005). https://doi.org/10.1111/j.1525-1497.2005.0124.x

  24. R. Ortiz, K.H. Hupart, C.R. DeFesi, M.I. Surks. Effect of early referral to an endocrinologist on efficiency and cost of evaluation and development of treatment plan in patients with thyroid nodules. J. Clin. Endocrinol. Metab. (1998). https://doi.org/10.1210/jcem.83.11.5268

  25. R. Veeramachaneni, R.A. Anbari, N. Marenych, S. Patel, et al. The impact of the association of unnecessarily ordered ultrasounds (USGS) and unnecessarily requirested endocrinology consultations. J. Endocr. Soc. (2020). https://doi.org/10.1210/jendso/bvaa046

  26. K. Barret, A. Kennedy, A. Repp, M. Gilbert. Predictors and consequences of inappropriate thyroid ultrasound. Thyroid (2019). https://doi.org/10.1089/thy.2019.29085.abstracts

  27. Endocrine Society - Thyroid ultrasounds | Choosing Wisely. (2020). https://www.choosingwisely.org/clinician-lists/endocrine-society-thyroid-ultrasounds-in-patients-with-abnormal-thyroid-function-tests/. Accessed 20 Aug 2020

  28. B. Nickel, A. Barratt, K. McGeechan, J.P. Brito, et al. Effect of a change in papillary thyroid cancer terminology on anxiety levels and treatment preferences: a randomized crossover trial. JAMA Otolaryngol. - Head Neck Surg. (2018). https://doi.org/10.1001/jamaoto.2018.1272

  29. P. Shih, B. Nickel, C. Degeling, R. Thomas, et al. Terminology change for small low-risk papillary thyroid cancer as a response to overtreatment: results from three Australian community juries. Thyroid (2021). https://doi.org/10.1089/thy.2020.0694

  30. B.G. Cavalheiro, L.L. Matos, A.K.N. Leite, M.A.V. Kulcsar, et al. Surgical treatment for thyroid carcinoma: retrospective study with 811 patients in a Brazilian tertiary hospital. Arch. Endocrinol. Metab. (2016). https://doi.org/10.1590/2359-3997000000209

  31. B. Kohnen, C. Schürmeyer, T.H. Schürmeyer, P. Kress. Surgery of benign thyroid disease by ENT/head and neck surgeons and general surgeons: 233 cases of vocal fold paralysis in 3509 patients. Eur Arch Oto-Rhino-Laryngology (2018). https://doi.org/10.1007/s00405-018-5077-2

  32. M.A. Adam, S. Thomas, L. Youngwirth, T. Hyslop, et al. Is there a minimum number of thyroidectomies a surgeon should perform to optimize patient outcomes? Ann. Surg. (2017). https://doi.org/10.1097/SLA.0000000000001688

  33. D.W. Chen, D. Reyes-Gastelum, A. Radhakrishnan, A.S. Hamilton, et al. Physician-reported misuse of thyroid ultrasonography. JAMA Surg. (2020). https://doi.org/10.1001/jamasurg.2020.2507

Download references

Funding

No funding was provided for this endeavor. N.S.O. was supported by the National Cancer Institute of the National Institutes of Health under Award Number K08CA248972. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. S.M. was supported by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000, and by the United States Department of Veterans Affairs Health Services Research & Development Service of the VA Office of Research and Development, under Merit review award number 1I21HX003268-01A1. The views expressed in the article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs or the United States Government.

Author information

Authors and Affiliations

Authors

Contributions

M.K.E. carried out the collection of data and drafted the manuscript. N.M.I-A. carried out the selection and collection of data and reviewed the manuscript. N.S.O. conceived of the study, participated in its design, and reviewed the manuscript. E.L-N. performed statistical analyses and reviewed the manuscript. S.M. conceived of the study, participated in its design, and reviewed the manuscript. J.P.B. conceived of the study, participated in its design, carried out selection of data, performed statistical analyses, and drafted the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Juan P. Brito.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Edwards, M.K., Iñiguez-Ariza, N.M., Singh Ospina, N. et al. Inappropriate use of thyroid ultrasound: a systematic review and meta-analysis. Endocrine 74, 263–269 (2021). https://doi.org/10.1007/s12020-021-02820-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12020-021-02820-z

Keywords

Navigation